The National Agency for Food and Drug Administration and Control (NAFDAC) has authorized the emergency use of three COVID-19 vaccines, Moderna, AstraZeneca and Sputnik V.
NAFDAC’s Director-General, Mojisola Adeyeye, announced this on Thursday at the agency’s headquarters in Abuja.
The AstraZeneca vaccine approved is from Korea due to the stall in the procurement of the AstraZeneca vaccine manufactured in India.
Recall that NAFDAC had approved AstraZeneca (India), Pfizer bioNTech and Johnson & Johnson COVID-19 vaccines in February and May 2021, respectively.
